Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 41,557 | 48,730 | 48,191 | 44,978 | 42,083 |
| Cost of Goods | 18,767 | 18,967 | 16,429 | 16,440 | 16,445 |
| Gross Profit | 22,790 | 29,763 | 31,762 | 28,538 | 25,638 |
| Operating Expenses | 26,377 | -15,060 | 24,226 | 22,191 | 20,692 |
| Operating Income | -2,820 | 45,790 | 7,965 | 6,787 | 5,391 |
| Interest Expense | 174 | 764 | 750 | 1,135 | 962 |
| Other Income | -144 | 78 | 6 | -89 | -46 |
| Pre-tax Income | -3,138 | 45,104 | 7,221 | 5,563 | 4,383 |
| Income Tax | -817 | 12,421 | 1,828 | 1,143 | 590 |
| Net Income Continuous | -2,321 | 32,683 | 5,393 | 4,420 | 3,793 |
| Net Income | $-2,321 | $32,683 | $5,393 | $4,420 | $3,793 |
| EPS Basic Total Ops | -0.01 | 0.19 | 0.03 | 0.03 | 0.02 |
| EPS Basic Continuous Ops | -0.01 | 0.19 | 0.03 | 0.03 | 0.02 |
| EPS Diluted Total Ops | -0.01 | 0.18 | 0.03 | 0.03 | 0.02 |
| EPS Diluted Continuous Ops | -0.01 | 0.19 | 0.03 | 0.03 | 0.02 |
| EPS Diluted Before Non-Recurring Items | -0.01 | 0.02 | 0.03 | 0.03 | 0.02 |
| EBITDA(a) | $-1,889 | $46,930 | $8,911 | $7,708 | $6,285 |